-- Robert Preidt
WEDNESDAY, Nov. 20, 2013 (HealthDay News) -- A new therapy may
help lower tough-to-treat high blood pressure in people with
chronic kidney disease, a new study finds.
"Blood pressure that is difficult to control, even on multiple medications, in patients with chronic kidney disease is a significant issue," explained an expert who was not connected to the new study, Dr. Adam Auerbach.
"Poorly controlled blood pressure can lead to worsening kidney function, heart disease and stroke," said Auerbach, who is a cardiologist at North Shore University Hospital in Manhasset, and Long Island Jewish Medical Center in New Hyde Park, N.Y.
The new technique is called renal (kidney) denervation, and
involves the interruption of a key nerve in the kidney. It is a
minimally invasive, catheter-based procedure that uses radio waves
to heat and remove tissue.
The study included 15 people averaging 66 years of age. All had
chronic kidney disease along with high blood pressure that had
proven resistant to standard drugs, even though the patients were
taking at least three medications to lower their blood
All of the patients underwent renal denervation and were
followed for one year. During that time, the patients were treated
with an average of five different medications for high blood
The patients' blood pressure decreased significantly during the
follow-up and their kidney function remained stable and did not
further deteriorate, the researchers noted.
The small pilot study suggests that "treatment with renal
denervation decreases blood pressure, and most important, slows or
even halts the decline of [kidney] function in treatment-resistant
patients with chronic kidney disease," study lead author Dr. Roland
Schmieder said in a news release from the American Heart
Auerbach cautioned that renal denervation "is in addition to
taking medications, it does not replace them." He added that "this
is a promising procedure, but the number of patients in this study
was small and further investigation is needed."
Another expert was similarly cautious.
While the finding could be of "great clinical significance" to
patients, "it remains to be seen if this stoppage of renal function
decline by renal denervation therapy translates into lives saved or
[heart attacks] prevented," said Dr. Sripal Bangalore, assistant
professor in the department of medicine at NYU Langone Medical
Center in New York City.
"Nevertheless, if these results are replicated in other large trials this could potentially be a game-changer for patients with kidney disease and resistant hypertension [high blood pressure]," Bangalore said.
The study is scheduled for presentation Nov. 20 at the annual
meeting of the American Heart Association in Dallas. Findings
presented at medical meetings are typically considered preliminary
until published in a peer-reviewed journal.
The American Academy of Family Physicians has more about
high blood pressure.
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Information Services. All rights reserved.